The Effects of Caffeine on Human Spinal Motoneurons

NCT04891393 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-04-08

No results posted yet for this study

Summary

This study evaluates the effects of orally ingested, commercially available, coffee (3 mg/kg of caffeine) on the excitability of human spinal motoneurons of the lower leg.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Coffee

Starbucks brand "Via" instant coffee. (Caffeine Content: 3 mg / kg)

DIETARY_SUPPLEMENT

Decaffeinated coffee

Starbucks brand "Via" instant decaffeinated coffee. (Caffeine Content: 15 - 25 mg)

Sponsors & Collaborators

  • Temple University

    lead OTHER

Principal Investigators

  • Christopher Thompson, PT, PhD · Temple University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2022-03-28
Completion
2022-03-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04891393 on ClinicalTrials.gov